The Mexico oxygen concentrator market size reached USD 42.00 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 78.84 Million by 2033, exhibiting a growth rate (CAGR) of 6.50% during 2025-2033. The market is experiencing robust growth driven by the rising prevalence of respiratory diseases like COPD and asthma, and advancements in portable and stationary oxygen concentrators, especially in home healthcare settings. Government initiatives and healthcare infrastructure improvements and aging population that seeks reliable oxygen therapy solutions are further boosting the Mexico oxygen concentrator market share.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 42.00 Million |
Market Forecast in 2033 | USD 78.84 Million |
Market Growth Rate 2025-2033 | 6.50% |
Rising Incidence of Respiratory Diseases
Increasing incidence of respiratory diseases, including Chronic Obstructive Pulmonary Disease (COPD), asthma, and other chronic respiratory diseases, is significantly fueling the demand for oxygen concentrators in Mexico. COPD itself is a prime cause of disability and mortality, and with factors like smoking, pollution, and aging driving it up, there are more patients in need of long-term oxygen therapy. Asthma, which is another prevalent condition, also requires oxygen supplementation during exacerbations or acute attacks. With increasing prevalence of these diseases, oxygen concentrators are in greater demand to treat and relieve symptoms, allowing patients to live more comfortably at home. Oxygen therapy not only decreases hospital visits but also enhances the quality of life of patients with chronic respiratory disease. With this escalating demand, the Mexico oxygen concentrator market is witnessing substantial growth, as more patients opt for reliable and accessible solutions to monitor their respiratory well-being.
Growing Aging Population
Mexico's aging population is significantly contributing to the growing demand for oxygen concentrators. According to data published by PAHO, in 2024, Mexico's population reached 130,861,007, a 32.7% increase since 2000. Those aged 65 and older comprised 8.2% of the population, up 3.2 percentage points. The dependency ratio was 48.7 passive individuals per 100 active, down from 64.8 in 2000, highlighting demographic shifts over the years. As the elderly population increases, there is a higher incidence of age-related respiratory conditions, such as Chronic Obstructive Pulmonary Disease (COPD), emphysema, and pulmonary fibrosis. These conditions often require long-term oxygen therapy to manage oxygen levels and improve quality of life. For elderly patients, home-based oxygen therapy offers greater convenience and comfort, reducing the need for frequent hospital visits. Oxygen concentrators, both portable and stationary, are essential tools for these patients, allowing them to live independently while receiving necessary oxygen support. As the proportion of elderly individuals continues to rise, the need for effective and accessible oxygen concentrators is increasing. Government initiatives and advancements in healthcare technologies are further supporting the elderly in accessing these life-enhancing devices, fueling the Mexico oxygen concentrator market growth.
Shift to Home Healthcare
A significant trend towards home healthcare in Mexico is driven by the increasing demand for home oxygen therapy over hospitalization. Patients with chronic respiratory diseases such as COPD and asthma prefer receiving at-home oxygen therapy because of its cost savings, convenience, and comfort. Home oxygen therapy enables patients to self-manage their condition in a supportive environment, minimizing hospitalization and reducing the impact on their daily lives. This trend is important especially for elderly patients who need long-term oxygen therapy. Portable oxygen concentrators, enabling more mobility, have gained widespread usage because they enable individuals to lead normal daily activities while receiving required oxygen therapy. In addition, the increasing use of telemedicine and healthcare technology allows for improved monitoring of patient health at home, promoting the move to home healthcare. This shift is fueling the need for effective, easy-to-use oxygen concentrators in the market.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on type, technology, application, and end user.
Type Insights:
The report has provided a detailed breakup and analysis of the market based on the type. This includes portable and stationary.
Technology Insights:
A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes continuous flow and pulse flow.
Application Insights:
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes chronic obstructive pulmonary disease (COPD), asthma, respiratory distress, and others.
End User Insights:
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and clinics, home care settings, and ambulatory surgical centers and physician offices.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Northern Mexico, Central Mexico, Southern Mexico, and others.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Types Covered | Portable, Stationary |
Technologies Covered | Continuous Flow, Pulse Flow |
Applications Covered | Chronic Obstructive Pulmonary Disease (COPD), Asthma, Respiratory Distress, Others |
End Users Covered | Hospitals and Clinics, Home Care Settings, Ambulatory Surgical Centers and Physician Offices |
Regions Covered | Northern Mexico, Central Mexico, Southern Mexico, Others |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: